Overview:
Traditional preclinical models often fail to predict human outcomes, leading to high drug attrition rates. This resource explores how integrating organotypic 3D microtissue models with high-content live-cell analytics bridges the translational gap. Learn how these systems deliver real-time, multiparametric insights for oncology and toxicology, enabling earlier, data-driven decisions and reducing reliance on animal testing.
Resource type: Article
Page Count: 6 pages
Read Time: 5 minutes
Key Takeaways:
- Why 90% of drug candidates fail in clinical trials
- Advantages of organotypic 3D microtissue models over 2D cultures
- How high-content imaging enables real-time functional analysis
- Case studies in oncology and multi-organ toxicity assessment
- Ethical and regulatory benefits of human-relevant models
